Radiopharmaceuticals

DRUG2 trials

Sponsors

University of California, Berkeley, C Ray Therapeutics

Conditions

Alzheimer DiseaseMild Cognitive ImpairmentProgressive Supranuclear PalsyProstate Cancer

Early Phase 1

Tau Imaging With JNJ067

CompletedNCT03926702

University of California, BerkeleyAlzheimer Disease, Mild Cognitive Impairment, Progressive Supranuclear Palsy

Start: 2019-06-18End: 2021-01-06Updated: 2022-08-31

Phase 1

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC

RecruitingNCT07567521

C Ray TherapeuticsProstate Cancer

Start: 2026-05-22End: 2029-12-30Target: 90Updated: 2026-05-29